Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
504studies shown
Showing 26-50 of 504
CompletedNCT05841030

A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)

This study is completed. It focuses on depression and currently lists study information in Argentina, Brazil, Canada, France, Germany, Italy, South Korea, Spain, Sweden, the United Kingdom, and the United States.

DepressionOtherFrom 18 Years to 74 Years
Countries
Argentina, Brazil, Canada, France, Germany, Italy, South Korea, Spain, Sweden, United Kingdom, United States
Sponsor
Janssen Research & Development, LLC
Condition
Depression
TerminatedNCT05518149

A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD)

This study has public registry information. It focuses on depression and currently lists study information in Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, Czech Republic, France, Hungary, Italy, Poland, Portugal, Slovakia, South Africa, South Korea, Spain, Sweden, Taiwan, the United Kingdom, and the United States.

DepressionOtherFrom 18 Years to 74 Years
Countries
Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, Czech Republic, France, Hungary, Italy, Poland, Portugal, Slovakia, South Africa, South Korea, Spain, Sweden, Taiwan, United Kingdom, United States
Sponsor
Janssen Research & Development, LLC
Condition
Depression
RecruitingNCT07412756

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

This study is recruiting. It focuses on depression and currently lists participation information in Australia, Brazil, Canada, China, Germany, Greece, Japan, Mexico, Poland, the United States, South Korea, Spain, Taiwan, and the United Kingdom.

DepressionOtherFrom 18 Years to 75 Years
Countries
Australia, Brazil, Canada, China, Germany, Greece, Japan, Mexico, Poland, United States, South Korea, Spain, Taiwan, United Kingdom
Sponsor
Eli Lilly and Company
Condition
Depression
RecruitingNCT07196501

A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

This study is recruiting. It focuses on depression and currently lists participation information in Australia, Bulgaria, Canada, Estonia, Italy, Poland, Serbia, South Korea, Spain, Taiwan, and the United States.

DepressionOtherOver 18 Years
Countries
Australia, Bulgaria, Canada, Estonia, Italy, Poland, Serbia, South Korea, Spain, Taiwan, United States
Sponsor
Neurocrine Biosciences
Condition
Depression
RecruitingNCT06620276

ACT_for Alcohol Use Disorder and Depression

This study is recruiting. It focuses on depression and currently lists participation information in Canada.

DepressionOtherFrom 18 Years to 70 Years
Countries
Canada
Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Condition
Depression
RecruitingNCT04478305

Affect of Duavive on Mood & Anxiety Symptoms

This study is recruiting. It focuses on anxiety and currently lists participation information in Canada.

AnxietyDrugFrom 45 Years to 60 Years
Countries
Canada
Sponsor
St. Joseph's Healthcare Hamilton
Condition
Anxiety
Active Not RecruitingNCT02345122

CAMH PARTNERs Integrated Care Study

This study is active but not recruiting. It focuses on anxiety and currently lists study information in Canada.

AnxietyOtherOver 18 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Anxiety
RecruitingNCT04610697

Cognitive Remediation in Forensic Mental Health Care

This study is recruiting. It focuses on schizophrenia and currently lists participation information in Canada.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
Canada
Sponsor
The Royal Ottawa Mental Health Centre
Condition
Schizophrenia